Salubrinal inhibition was shown to lower the release of proinflammatory cytokines (IL-1β, IL-2, IL-13 and TNF) as well as the expression levels of Dusp2, and to attenuate arthritis in an anti-collagen antibody mouse model of RA [73,74]. The gene discussed is IL1B; the disease is rheumatoid arthritis.